B. Strober, “Effect of High-Dose Subcutaneous Spesolimab on Skin Manifestations: Results from the Pivotal Effisayil 2 Trial of Flare Prevention in Generalized Pustular Psoriasis”, J of Skin, vol. 8, no. 2, p. s371, Mar. 2024.